Xiaowei C. Li
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Proteogenomics of Hypertrophic Cardiomyopathy Reveals Subtype-Specific Therapy.
Journal: Circulation research
Published: July 01, 2026
USP10 Deubiquitinates MTX2 to Suppress cGAS-STING Signaling in MI.
Journal: Circulation research
Published: February 18, 2026
Generation of an induced pluripotent stem cell line (HPCHi002-A) derived from a dilated cardiomyopathy patient harboring heterozygous mutations c.644G > T (p.Arg215Leu) in the TNNT2 gene.
Journal: Stem cell research
Published: September 25, 2025
Decreased energy production and Ca2+ homeostasis imbalance induce myocardial hypertrophy in PDHA1-deficient human pluripotent stem cell derived cardiomyocytes.
Journal: Life sciences
Published: November 26, 2024
TAB2 deficiency induces dilated cardiomyopathy by promoting mitochondrial calcium overload in human iPSC-derived cardiomyocytes.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 18, 2024
ROS accelerates the progression of hypertrophic cardiomyopathy.
Journal: Genes & diseases
Published: June 19, 2024
Generation of a human induced pluripotent stem cell line ZZUNEUi030-A from a female patient carrying a heterozygous CALM2 (c.395 A > T) mutation.
Journal: Stem cell research
Published: June 05, 2024
Mitochondrial transplantation rescues Ca2+ homeostasis imbalance and myocardial hypertrophy in SLC25A3-related hypertrophic cardiomyopathy.
Journal: Cell reports
Published: May 13, 2024
Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models.
Journal: The Journal of clinical investigation
Published: November 01, 2023
Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
Journal: Stem cell research
Published: October 18, 2023
Last Updated: 09/26/2026